Fluid Removal Technology

Renephra Ltd is a medical device company, developing a groundbreaking technology for minimally invasive fluid removal to addresses the significant problems of fluid overload and chronic oedema / lymphoedema in vascular, oncology and other disease areas.

This is a substantial patient group with unmet clinical needs and is an estimated £1.8 billion market worldwide.

Recently Renephra achieved proof of concept in humans and is now engaged in raising capital to develop and CE mark the first device.